Cargando…

Comorbidity and risk factors of subsequent lower extremity amputation in patients diagnosed with diabetes in Saskatchewan, Canada

OBJECTIVE: Subsequent limb amputation (SLA) may be necessary due to disease progression, infection, or to aid prosthesis fit. SLA in Saskatchewan has increased 3.2% from 2006 to 2019 with minor SLA increasing 9.6% during that period. Diabetes affects a large proportion of patients who require SLA; h...

Descripción completa

Detalles Bibliográficos
Autores principales: Essien, Samuel Kwaku, Zucker-Levin, Audrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655619/
https://www.ncbi.nlm.nih.gov/pubmed/36366747
http://dx.doi.org/10.1177/17423953221137891
_version_ 1785147964975480832
author Essien, Samuel Kwaku
Zucker-Levin, Audrey
author_facet Essien, Samuel Kwaku
Zucker-Levin, Audrey
author_sort Essien, Samuel Kwaku
collection PubMed
description OBJECTIVE: Subsequent limb amputation (SLA) may be necessary due to disease progression, infection, or to aid prosthesis fit. SLA in Saskatchewan has increased 3.2% from 2006 to 2019 with minor SLA increasing 9.6% during that period. Diabetes affects a large proportion of patients who require SLA; however, the impact of additional comorbidities is not clear. METHODS: First-episode subsequent lower extremity limb amputation (SLEA) cases with the presence/absence of diabetes, other comorbidities, and demographic characteristics from 2006–2019 were retrieved from Saskatchewan's Discharge Abstract Database. Logistic regression was performed to examine the magnitude of the odds of SLEA. RESULTS: Among the 956 first-episode SLEA patients investigated, 78.8% were diagnosed with diabetes. Of these, 76.1% were male and 83.0% were aged 50 + years. Three comorbidities: renal failure (AOR = 1.9, 95% Cl 1.1 − 3.0), hypertension (AOR = 3.0, 95% Cl 2.0 − 4.5), and congestive heart failure (AOR = 2.0, 95% CI 1.2 − 3.2), conferred the highest odds of SLEA. The odds of SLEA is greatest for those aged 50–69 years, males, Registered Indians, and associated with a prolonged hospital stay. DISCUSSION: These data are important as they may help medical providers identify patients at the highest risk of SLEA and target interventions to optimize outcomes.
format Online
Article
Text
id pubmed-10655619
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-106556192023-11-17 Comorbidity and risk factors of subsequent lower extremity amputation in patients diagnosed with diabetes in Saskatchewan, Canada Essien, Samuel Kwaku Zucker-Levin, Audrey Chronic Illn Articles OBJECTIVE: Subsequent limb amputation (SLA) may be necessary due to disease progression, infection, or to aid prosthesis fit. SLA in Saskatchewan has increased 3.2% from 2006 to 2019 with minor SLA increasing 9.6% during that period. Diabetes affects a large proportion of patients who require SLA; however, the impact of additional comorbidities is not clear. METHODS: First-episode subsequent lower extremity limb amputation (SLEA) cases with the presence/absence of diabetes, other comorbidities, and demographic characteristics from 2006–2019 were retrieved from Saskatchewan's Discharge Abstract Database. Logistic regression was performed to examine the magnitude of the odds of SLEA. RESULTS: Among the 956 first-episode SLEA patients investigated, 78.8% were diagnosed with diabetes. Of these, 76.1% were male and 83.0% were aged 50 + years. Three comorbidities: renal failure (AOR = 1.9, 95% Cl 1.1 − 3.0), hypertension (AOR = 3.0, 95% Cl 2.0 − 4.5), and congestive heart failure (AOR = 2.0, 95% CI 1.2 − 3.2), conferred the highest odds of SLEA. The odds of SLEA is greatest for those aged 50–69 years, males, Registered Indians, and associated with a prolonged hospital stay. DISCUSSION: These data are important as they may help medical providers identify patients at the highest risk of SLEA and target interventions to optimize outcomes. SAGE Publications 2022-11-10 2023-12 /pmc/articles/PMC10655619/ /pubmed/36366747 http://dx.doi.org/10.1177/17423953221137891 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Articles
Essien, Samuel Kwaku
Zucker-Levin, Audrey
Comorbidity and risk factors of subsequent lower extremity amputation in patients diagnosed with diabetes in Saskatchewan, Canada
title Comorbidity and risk factors of subsequent lower extremity amputation in patients diagnosed with diabetes in Saskatchewan, Canada
title_full Comorbidity and risk factors of subsequent lower extremity amputation in patients diagnosed with diabetes in Saskatchewan, Canada
title_fullStr Comorbidity and risk factors of subsequent lower extremity amputation in patients diagnosed with diabetes in Saskatchewan, Canada
title_full_unstemmed Comorbidity and risk factors of subsequent lower extremity amputation in patients diagnosed with diabetes in Saskatchewan, Canada
title_short Comorbidity and risk factors of subsequent lower extremity amputation in patients diagnosed with diabetes in Saskatchewan, Canada
title_sort comorbidity and risk factors of subsequent lower extremity amputation in patients diagnosed with diabetes in saskatchewan, canada
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655619/
https://www.ncbi.nlm.nih.gov/pubmed/36366747
http://dx.doi.org/10.1177/17423953221137891
work_keys_str_mv AT essiensamuelkwaku comorbidityandriskfactorsofsubsequentlowerextremityamputationinpatientsdiagnosedwithdiabetesinsaskatchewancanada
AT zuckerlevinaudrey comorbidityandriskfactorsofsubsequentlowerextremityamputationinpatientsdiagnosedwithdiabetesinsaskatchewancanada